Published in Parasite Immunol on February 01, 1998
Concepts in immunology and diagnosis of hydatid disease. Clin Microbiol Rev (2003) 2.77
Improved immunodiagnosis of cystic hydatid disease by using a synthetic peptide with higher diagnostic value than that of its parent protein, Echinococcus granulosus antigen B. J Clin Microbiol (2000) 1.26
Bone hydatid disease. Postgrad Med J (2007) 1.18
Comparative analysis of the diagnostic performance of six major Echinococcus granulosus antigens assessed in a double-blind, randomized multicenter study. J Clin Microbiol (2005) 1.01
Echinococcus granulosus antigen 5 is closely related to proteases of the trypsin family. Biochem J (2003) 0.96
Serological diagnosis of lung cystic hydatid disease using the synthetic p176 peptide. Clin Vaccine Immunol (2012) 0.90
Taenia saginata metacestode antigenic fractions without affinity to concanavalin A are an important source of specific antigens for the diagnosis of human neurocysticercosis. Clin Vaccine Immunol (2010) 0.87
Identification of a specific antigenic region of the P82 protein of Babesia equi and its potential use in serodiagnosis. J Clin Microbiol (2003) 0.84
Saline extract of Taenia saginata metacestodes as an alternative antigen for the immunodiagnosis of neurocysticercosis in human cerebrospinal fluid. Parasitol Res (2009) 0.77
Serodiagnosis of human neurocysticercosis using antigenic components of Taenia solium metacestodes derived from the unbound fraction from jacalin affinity chromatography. Mem Inst Oswaldo Cruz (2013) 0.75
Cloning of the beta cell high-affinity sulfonylurea receptor: a regulator of insulin secretion. Science (1995) 6.91
Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs. Am J Hum Genet (2000) 3.44
Eukaryotic translation initiation factor 4GI is a cellular target for NS1 protein, a translational activator of influenza virus. Mol Cell Biol (2000) 2.48
Nucleotide sequence of two rasH related-genes isolated from the yeast Saccharomyces cerevisiae. Nucleic Acids Res (1984) 2.10
Factors related to the development of CMV-specific CD8+ T cell response in CMV-seropositive solid organ transplant candidates. Am J Transplant (2015) 2.08
Effect of silymarin plus vitamin E in patients with non-alcoholic fatty liver disease. A randomized clinical pilot study. Eur Rev Med Pharmacol Sci (2015) 2.05
Individual expression of influenza virus PA protein induces degradation of coexpressed proteins. J Virol (1995) 2.02
[Identification of gaps in the clinical patient care of asthma in Spain. Results of the OPTIMA-GEMA survey]. An Sist Sanit Navar (2016) 2.02
PA subunit from influenza virus polymerase complex interacts with a cellular protein with homology to a family of transcriptional activators. J Virol (2001) 1.98
Monoclonal antibodies against influenza virus PB2 and NP polypeptides interfere with the initiation step of viral mRNA synthesis in vitro. J Virol (1994) 1.93
Allergy testing in children: why, who, when and how? Allergy (2003) 1.86
Synthesis of biologically active influenza virus core proteins using a vaccinia virus-T7 RNA polymerase expression system. J Gen Virol (1994) 1.83
The amino-terminal one-third of the influenza virus PA protein is responsible for the induction of proteolysis. J Virol (1996) 1.79
International consensus on (ICON) pediatric asthma. Allergy (2012) 1.79
Inactivation of phosphofructokinase by glucagon in rat hepatocytes. J Biol Chem (1979) 1.76
The replication activity of influenza virus polymerase is linked to the capacity of the PA subunit to induce proteolysis. J Virol (2000) 1.69
Influenza virus infection causes specific degradation of the largest subunit of cellular RNA polymerase II. J Virol (2007) 1.64
Direct measurement of antibody affinity distribution by hapten-inhibition enzyme immunoassay. Mol Immunol (1984) 1.61
Codon 178 mutation in ethnically diverse Creutzfeldt-Jakob disease families. Lancet (1991) 1.56
Subepithelial myofibroblasts and tenascin expression in microscopic colitis. Histopathology (2003) 1.51
The N-terminal half of the influenza virus NS1 protein is sufficient for nuclear retention of mRNA and enhancement of viral mRNA translation. Nucleic Acids Res (1997) 1.48
Carotid artery stenting without angioplasty and cerebral protection: a single-center experience with up to 7 years' follow-up. AJNR Am J Neuroradiol (2011) 1.48
Viruses and bacteria in acute asthma exacerbations--a GA² LEN-DARE systematic review. Allergy (2010) 1.45
Mutational analysis of the influenza virus A/Victoria/3/75 PA protein: studies of interaction with PB1 protein and identification of a dominant negative mutant. J Gen Virol (1996) 1.43
An upper limit on the stochastic gravitational-wave background of cosmological origin. Nature (2009) 1.42
Activation of phospholipid methyltransferase by glucagon in rat hepatocytes. J Biol Chem (1980) 1.41
Allergy to latex in spina bifida: a multivariate study of associated factors in 100 consecutive patients. J Allergy Clin Immunol (1996) 1.38
Two classes of MHC class II interactions with the TCR. Immunol Today (1998) 1.38
Fetal cardiotocography and acid-base status during cesarean section. Eur J Obstet Gynecol Reprod Biol (1998) 1.38
Phase II clinical trial of neoadjuvant trabectedin in patients with advanced localized myxoid liposarcoma. Ann Oncol (2011) 1.36
A set of recombinant antigens from Echinococcus granulosus with potential for use in the immunodiagnosis of human cystic hydatid disease. Clin Exp Immunol (2003) 1.33
The PA influenza virus polymerase subunit is a phosphorylated protein. J Gen Virol (1998) 1.33
Predictive impact of DNA repair functionality on clinical outcome of advanced sarcoma patients treated with trabectedin: a retrospective multicentric study. Eur J Cancer (2011) 1.27
Replication of orthomyxoviruses. Adv Virus Res (1999) 1.27
Improved immunodiagnosis of cystic hydatid disease by using a synthetic peptide with higher diagnostic value than that of its parent protein, Echinococcus granulosus antigen B. J Clin Microbiol (2000) 1.26
Molecular characterisation of a novel 8-kDa subunit of Echinococcus granulosus antigen B. Mol Biochem Parasitol (1996) 1.22
Kinase activity of oxygen sensor FixL depends on the spin state of its heme iron. Biochemistry (1995) 1.19
Small cell carcinoma of the urinary bladder treated with chemotherapy and radiotherapy: results in five cases. Eur Urol (1999) 1.18
Trabectedin plus pegylated liposomal doxorubicin in relapsed ovarian cancer delays third-line chemotherapy and prolongs the platinum-free interval. Ann Oncol (2010) 1.15
New mutation in scrapie amyloid precursor gene (at codon 178) in Finnish Creutzfeldt-Jakob kindred. Lancet (1991) 1.13
IL-6 promoter polymorphisms in rheumatoid arthritis. Genes Immun (2000) 1.13
Two different 8 kDa monomers are involved in the oligomeric organization of the native Echinococcus granulosus antigen B. Parasite Immunol (1996) 1.12
Multicenter phase II study of trabectedin in patients with metastatic castration-resistant prostate cancer. Ann Oncol (2011) 1.11
Upper limits on a stochastic background of gravitational waves. Phys Rev Lett (2005) 1.11
Open reading frame 5 of porcine reproductive and respiratory syndrome virus as a cause of virus-induced apoptosis. J Virol (1996) 1.09
Distribution of hepatitis B virus (HBV) markers in blood donors of 13 Western Hemisphere countries: proceedings of the Red Cross Latin American hepatitis B workshop. Bull Pan Am Health Organ (1980) 1.09
Prevalence of pre-obesity and obesity in urban adult Mexicans in comparison with other large surveys. Obes Res (2000) 1.08
Comparison of risk patterns in carcinoma and melanoma of the skin in men: a multi-centre case-case-control study. Br J Cancer (2006) 1.08
Role of cytokines (interleukin-1beta, 6, 8, tumour necrosis factor-alpha, and soluble receptor of interleukin-2) and C-reactive protein in the diagnosis of neonatal sepsis. Acta Paediatr (2003) 1.08
Epitope mapping of cross-reactive monoclonal antibodies specific for the influenza A virus PA and PB2 polypeptides. Virus Res (1995) 1.08
Comparative analysis of two different subunits of antigen B from Echinococcus granulosus: gene sequences, expression in Escherichia coli and serological evaluation. Acta Trop (2000) 1.07
Polymorphism at the TNF loci in rheumatoid arthritis. Tissue Antigens (1997) 1.06
[Acute heart failure in patients over 70 years of age: Precipitating factors of decompensation]. Rev Clin Esp (2010) 1.06
Antibodies to vimentin intermediate filaments in sera from patients with systemic lupus erythematosus. Arthritis Rheum (1984) 1.05
Association of ATG16L1 and IRGM genes polymorphisms with inflammatory bowel disease: a meta-analysis approach. Genes Immun (2009) 1.05
Autoradiographic study of development of the cerebral cortex in the rabbit. Brain Behav Evol (1974) 1.04
Association of the macrophage migration inhibitory factor gene polymorphisms with inflammatory bowel disease. Gut (2007) 1.04
Creutzfeldt-Jakob disease cosegregates with the codon 178Asn PRNP mutation in families of European origin. Ann Neurol (1992) 1.04
Use of specific antibody and circulating antigen serum levels in the hydatid immunodiagnosis of asymptomatic population. Int J Parasitol (1994) 1.03
Prevalence and types of class 1 integrons in aminoglycoside-resistant Enterobacteriaceae from several Chilean hospitals. J Antimicrob Chemother (2003) 1.02
Genetic stability of human embryonic stem cells: A first-step toward the development of potential hESC-based systems for modeling childhood leukemia. Leuk Res (2008) 1.02
Rotavirus-associated medical visits and hospitalizations in South America: a prospective study at three large sentinel hospitals. Pediatr Infect Dis J (2001) 1.01
Molecular characterization of P-29, a metacestode-specific component of Echinococcus granulosus which is immunologically related to, but distinct from, antigen 5. Mol Biochem Parasitol (2000) 1.01
Prevalence of Toxoplasma gondii in cats from Colombia, South America and genetic characterization of T. gondii isolates. Vet Parasitol (2006) 1.01
Perspectives on allergen-specific immunotherapy in childhood: an EAACI position statement. Pediatr Allergy Immunol (2012) 1.00
Immunohistological features of visceral leishmaniasis in BALB/c mice. Parasite Immunol (2006) 1.00
The effect of expression levels on codon usage in Plasmodium falciparum. Parasitology (2004) 1.00
Identity tests: determination of cell line cross-contamination. Cytotechnology (2006) 0.99
Oral and oropharyngeal cancer in Spain: influence of dietary patterns. Eur J Cancer Prev (2003) 0.98
Furosemide-induced adverse reactions in cirrhosis of the liver. Clin Pharmacol Ther (1979) 0.98
A probiotic strain of Escherichia coli, Nissle 1917, given orally exerts local and systemic anti-inflammatory effects in lipopolysaccharide-induced sepsis in mice. Br J Pharmacol (2009) 0.97
Use of CD63 expression as a marker of in vitro basophil activation and leukotriene determination in metamizol allergic patients. Allergy (2003) 0.97
Bacterial pathogens associated with bloody diarrhea in Uruguayan children. Rev Argent Microbiol (2010) 0.96
CLL-like B-lymphocytes are systematically present at very low numbers in peripheral blood of healthy adults. Leukemia (2011) 0.96
Acoustic voice analysis in patients with Parkinson's disease treated with dopaminergic drugs. J Voice (1997) 0.96
Testing children for allergies: why, how, who and when: an updated statement of the European Academy of Allergy and Clinical Immunology (EAACI) Section on Pediatrics and the EAACI-Clemens von Pirquet Foundation. Pediatr Allergy Immunol (2013) 0.95
Translation of the mRNA for rabbit uteroglobin in cell-free systems. Evidence for a precursor protein. Eur J Biochem (1976) 0.95
Rheumatoid arthritis in southern Spain: toward elucidation of a unifying role of the HLA class II region in disease predisposition. Arthritis Rheum (2001) 0.95
Trabectedin is a feasible treatment for soft tissue sarcoma patients regardless of patient age: a retrospective pooled analysis of five phase II trials. Br J Cancer (2013) 0.95
O-glycosylation in Echinococcus granulosus: identification and characterization of the carcinoma-associated Tn antigen. Exp Parasitol (2001) 0.95
Environmental deprivation delays the maturation of motor pyramids during the early postnatal period. Early Hum Dev (1993) 0.95
Avidity analysis of the human immune response to a chitin binding protein of Toxoplasma gondii. Int J Parasitol (2001) 0.95
Cord blood levels of cytokines as predictors of early neonatal sepsis. Acta Paediatr (2001) 0.93
Bone turnover and density in healthy women during breastfeeding and after weaning. Osteoporos Int (1996) 0.93
Directional limits on persistent gravitational waves using LIGO S5 science data. Phys Rev Lett (2011) 0.93
Acoustic voice analysis in patients with essential tremor. J Voice (1998) 0.92
Chemokine receptor CCR5 polymorphisms and Chagas' disease cardiomyopathy. Tissue Antigens (2001) 0.92
Clusters of drug involvement in Panama: results from Panama's 1996 National Youth Survey. Drug Alcohol Depend (2000) 0.92
IgG recognizing 21-24 kDa and 30-33 kDa tachyzoite antigens show maximum avidity maturation during natural and accidental human toxoplasmosis. Rev Inst Med Trop Sao Paulo (2000) 0.91
Multiple sclerosis prevalence in Malaga, Southern Spain estimated by the capture-recapture method. Mult Scler (2011) 0.91
Parity and the prevalence of overweight. Int J Gynaecol Obstet (1995) 0.91
Glucocorticoid and developmental regulation of uteroglobin synthesis in rabbit lung. Biochem J (1981) 0.90
Calcitonin biosynthesis: evidence for a precursor. Eur J Biochem (1975) 0.90
Growth modulation index as metric of clinical benefit assessment among advanced soft tissue sarcoma patients receiving trabectedin as a salvage therapy. Ann Oncol (2012) 0.90
An autoradiographic study of the development of the anterior thalamic group and limbic cortex in the rabbit. J Comp Neurol (1969) 0.90
Ion transport in tumors under electrochemical treatment: in vivo, in vitro and in silico modeling. Bioelectrochemistry (2007) 0.90
Control in vivo of rat liver phosphofructokinase by glucagon and nutritional changes. Biochem J (1980) 0.90